BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31056361)

  • 1. Prevalence and characteristics of anti-HCV positivity and chronic hepatitis C virus infection in HFE p.C282Y homozygotes.
    Barton JC; Barton JC; Adams PC
    Ann Hepatol; 2019; 18(2):354-359. PubMed ID: 31056361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet counts in
    Barton JC; Barton JC; Acton RT
    Platelets; 2023 Dec; 34(1):2217933. PubMed ID: 37260121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HFE p.C282Y homozygosity predisposes to rapid serum ferritin rise after menopause: A genotype-stratified cohort study of hemochromatosis in Australian women.
    Warne CD; Zaloumis SG; Bertalli NA; Delatycki MB; Nicoll AJ; McLaren CE; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ; Gurrin LC;
    J Gastroenterol Hepatol; 2017 Apr; 32(4):797-802. PubMed ID: 27784128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis.
    Allen KJ; Bertalli NA; Osborne NJ; Constantine CC; Delatycki MB; Nisselle AE; Nicoll AJ; Gertig DM; McLaren CE; Giles GG; Hopper JL; Anderson GJ; Olynyk JK; Powell LW; Gurrin LC;
    Hepatology; 2010 Sep; 52(3):925-33. PubMed ID: 20583211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
    Barton JC; Acton RT; Leiendecker-Foster C; Lovato L; Adams PC; McLaren GD; Eckfeldt JH; McLaren CE; Reboussin DM; Gordeuk VR; Speechley MR; Reiss JA; Press RD; Dawkins FW;
    Genet Test; 2007; 11(3):269-75. PubMed ID: 17949288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants and characteristics of mean corpuscular volume and hemoglobin concentration in white HFE C282Y homozygotes in the hemochromatosis and iron overload screening study.
    McLaren CE; Barton JC; Gordeuk VR; Wu L; Adams PC; Reboussin DM; Speechley M; Chang H; Acton RT; Harris EL; Ruggiero AM; Castro O;
    Am J Hematol; 2007 Oct; 82(10):898-905. PubMed ID: 17597476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron overload phenotypes and HFE genotypes in white hemochromatosis and iron overload screening study participants without HFE p.C282Y/p.C282Y.
    Barton JC; Barton JC; Acton RT
    PLoS One; 2022; 17(7):e0271973. PubMed ID: 35895739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor necrosis factor-alpha promoter variants and iron phenotypes in 785 hemochromatosis and iron overload screening (HEIRS) study participants.
    Acton RT; Barton JC; Leiendecker-Foster C; Zaun C; McLaren CE; Eckfeldt JH
    Blood Cells Mol Dis; 2010 Apr; 44(4):252-6. PubMed ID: 20178892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Hemochromatosis HFE p.C282Y Homozygosity With Hepatic Malignancy.
    Atkins JL; Pilling LC; Masoli JAH; Kuo CL; Shearman JD; Adams PC; Melzer D
    JAMA; 2020 Nov; 324(20):2048-2057. PubMed ID: 33231665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes.
    Barton JC; McLaren CE; Chen WP; Ramm GA; Anderson GJ; Powell LW; Subramaniam VN; Adams PC; Phatak PD; Gurrin LC; Phillips JD; Parker CJ; Emond MJ; McLaren GD
    Ann Hepatol; 2018 Aug; 17(5):871-879. PubMed ID: 30145563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Searching for hereditary hemochromatosis.
    Laudicina RJ
    Clin Lab Sci; 2006; 19(3):174-83. PubMed ID: 16910235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HFE mutations and chronic hepatitis C: H63D and C282Y heterozygosity are independent risk factors for liver fibrosis and cirrhosis.
    Erhardt A; Maschner-Olberg A; Mellenthin C; Kappert G; Adams O; Donner A; Willers R; Niederau C; Häussinger D
    J Hepatol; 2003 Mar; 38(3):335-42. PubMed ID: 12586300
    [TBL] [Abstract][Full Text] [Related]  

  • 13.  GNPAT variant (D519G) is not associated with an elevated serum ferritin or iron removed by phlebotomy in patients referred for C282Y-linked hemochromatosis.
    Levstik A; Stuart A; Adams PC
    Ann Hepatol; 2016 Nov-Dec 2016; 15(6):907-910. PubMed ID: 27740525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial serum ferritin measurements in untreated HFE C282Y homozygotes in the Hemochromatosis and Iron Overload Screening Study.
    Adams PC; Reboussin DM; Barton JC; Acton RT; Speechley M; Leiendecker-Foster C; Meenan R; Passmore L; McLaren CE; McLaren GD; Gordeuk V; Dawkins F; Eckfeldt JH
    Int J Lab Hematol; 2008 Aug; 30(4):300-5. PubMed ID: 18665827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thyroid-stimulating hormone and free thyroxine levels in persons with HFE C282Y homozygosity, a common hemochromatosis genotype: the HEIRS study.
    Barton JC; Leiendecker-Foster C; Reboussin DM; Adams PC; Acton RT; Eckfeldt JH;
    Thyroid; 2008 Aug; 18(8):831-8. PubMed ID: 18651828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial screening transferrin saturation values, serum ferritin concentrations, and HFE genotypes in whites and blacks in the Hemochromatosis and Iron Overload Screening Study.
    Barton JC; Acton RT; Dawkins FW; Adams PC; Lovato L; Leiendecker-Foster C; McLaren CE; Reboussin DM; Speechley MR; Gordeuk VR; McLaren GD; Sholinsky P; Harris EL
    Genet Test; 2005; 9(3):231-41. PubMed ID: 16225403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bivariate mixture models for the joint distribution of repeated serum ferritin and transferrin saturation measured 12 years apart in a cohort of healthy middle-aged Australians.
    McLaren CE; Chen WP; Bertalli NA; Delatycki MB; Giles GG; English DR; Hopper JL; Allen KJ; Gurrin LC
    PLoS One; 2019; 14(3):e0214196. PubMed ID: 30913256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HFE, SLC40A1, HAMP, HJV, TFR2, and FTL mutations detected by denaturing high-performance liquid chromatography after iron phenotyping and HFE C282Y and H63D genotyping in 785 HEIRS Study participants.
    Barton JC; Lafreniere SA; Leiendecker-Foster C; Li H; Acton RT; Press RD; Eckfeldt JH
    Am J Hematol; 2009 Nov; 84(11):710-4. PubMed ID: 19787796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study.
    Pankow JS; Boerwinkle E; Adams PC; Guallar E; Leiendecker-Foster C; Rogowski J; Eckfeldt JH
    Transl Res; 2008 Jul; 152(1):3-10. PubMed ID: 18593631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of serum iron indices for HFE C282Y homozygosity associated with hereditary hemochromatosis.
    Gurrin LC; Osborne NJ; Constantine CC; McLaren CE; English DR; Gertig DM; Delatycki MB; Southey MC; Hopper JL; Giles GG; Anderson GJ; Olynyk JK; Powell LW; Allen KJ;
    Gastroenterology; 2008 Dec; 135(6):1945-52. PubMed ID: 18848943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.